The AI Revolution Comes to Drugs

Posted on
AI Revolution Comes to Drugs

In today’s edition of the daily newsletter, we’re looking at the continuous spree of expectations and forecast for the oncoming months in 2025. This edition of special newsletter is enclosed with the following stories; the AI revolution comes to drugs followed by quest for establishing fusion power shifting from public to private sector. This newsletter is also enclosed with World Brief, catching you up on the past 24 hours of news in five minutes. The following news is covered; Impeachment once again in South Korea followed by TikTok law suit and updates on NATO and Israel-Hamas War.

Cover Story

Developing a drug is a complex process that often fails. It begins by identifying a target, such as a protein or gene, associated with a disease. Researchers then search for a molecule that can either block or enhance the target’s activity safely. This can involve screening as many as 1 million compounds before selecting just one or two promising candidates. Software can help to identify such molecules. But generative artificial intelligence (AI) can dream up entirely new ones to test. BCG, a consultancy, estimates that about 65 AI-inspired molecules are currently being tested on humans.

This content is for members only.

Featured Image Credit – J.P. Morgan

About the Author

Anirudh Phadke is the Founder/Editor of The Viyug. He is currently serving as a Member of the Board of Studies (BoS) for the Department of Defence & Strategic Studies at the Guru Nanak College (Autonomous). He previously worked for International Criminal Police Organization (INTERPOL). Anirudh holds a Master of Science in Strategic Studies along with a Certificate in Terrorism Studies from S. Rajaratnam School of International Studies (RSIS) at Nanyang Technological University (NTU). He completed Bachelor’s degree in Defence & Strategic Studies from Guru Nanak College (Autonomous).

Related Posts

This Year, Putin’s Way

On Thursday Vladimir Putin hosts his annual press conference, in which he answers softball questions about the year’s achivements at great length. Russia’s president may be cheerful. His forces continue to progress in eastern Ukraine, albeit at a cost of many men. And Donald Trump’s victory might provide a boon. Many people think he will keep his promise to end the war swiftly by imposing a bad deal on Ukraine. Still, the Russian president has plenty of problems.

10 Global Conflicts to Watch in 2025

In the Middle East, a chain of conflicts is taking place set off by Hamas’s Oct. 7, 2023, attack on Israel followed by the latter’s retaliation on Gaza Strip; Iran’s region wide attack through non-state proxies; and thus, setting a stage for Islamist rebels to topple the Assad’s regime, ending a half-century-old dictatorship in Syria. We also witnessed more aggression from Russia on Ukraine and thereby threatening a wider confrontation in Europe.

United States under Trump 2.0 wants the Panama Canal

Donald Trump recently claimed that the United States is being “ripped off” by the Panama Canal’s administrators and alleged that “Chinese soldiers” are operating the canal. He has threatened to “demand the return of the Panama Canal” to the United States. On December 23rd, Panama’s president, José Raúl Mulino, responded by asserting that “every square metre of the Panama Canal” is the country’s property, a stance supported by opposition parties. Trump’s actual objectives might be less extreme, but their specifics remain unclear

One thought on “The AI Revolution Comes to Drugs”

  1. Pingback: Constitutional Crisis in Georgia - THE VIYUG

Please Login to Comment.